Laboratory Assessment for Postoperative Bleeding Risk
For patients with suspected coagulopathy and excessive postoperative bleeding, obtain viscoelastic hemostatic assays (VHAs) such as TEG or ROTEM along with platelet count when available; if VHAs are unavailable, obtain standard coagulation tests (INR, aPTT, fibrinogen concentration) plus platelet count 1, 2.
The Evidence-Based Approach
Primary Testing Strategy
The 2015 ASA guidelines and 2025 Association of Anaesthetists guidelines converge on a clear hierarchy 1, 2:
When coagulopathy is suspected:
- First-line: Viscoelastic assays (TEG/ROTEM) + platelet count
- Alternative (if VHAs unavailable): INR, aPTT, fibrinogen concentration + platelet count
The key distinction here is that these tests should be obtained when excessive bleeding occurs or coagulopathy is suspected—not routinely for all postoperative patients.
Why Viscoelastic Assays Are Preferred
VHAs provide several advantages over traditional coagulation tests 2:
- Rapid turnaround time (results within minutes vs. hours)
- Comprehensive assessment of all phases of coagulation in real-time
- Point-of-care capability allowing immediate clinical decision-making
- Functional assessment of clot formation and breakdown
Recent pediatric cardiac surgery data (2026) demonstrates that CRT-MA (citrated rapid TEG maximum amplitude) and platelet count showed the highest predictive ability for early postoperative bleeding (AUC 0.74) 3. Notably, CFF-MA (functional fibrinogen) outperformed serum fibrinogen levels (AUC 0.72 vs. 0.42) 3.
Critical Caveat About Traditional Coagulation Tests
A major 2026 systematic review of 100 studies definitively shows that preoperative PT/INR and aPTT demonstrate weak or inconsistent association with bleeding events in nearly all elective surgeries 4. These tests are not reliable screening tools for predicting postoperative bleeding risk in most surgical contexts.
The exception: PT/INR may have value in patients with advanced liver disease undergoing major abdominal surgeries 4.
Specific Testing Algorithm for Active Bleeding
When a patient has excessive postoperative bleeding:
Step 1: Immediate Assessment
- Platelet count (critical for both VHA and traditional approaches)
- VHA testing (TEG or ROTEM) if available 1, 2
Step 2: If VHAs Are Available
Use manufacturer-specific thresholds. Example trauma algorithm 2:
- FIBTEM CA5 < 10 mm → Consider cryoprecipitate/fibrinogen replacement
- EXTEM CA5 - FIBTEM CA5 < 30 mm → Consider platelet transfusion
- EXTEM CT > 80 s with CA5 > 40 mm → Consider FFP
- EXTEM LI30 < 85% → Consider additional tranexamic acid
Step 3: If VHAs Are NOT Available
Obtain traditional panel 1:
- INR/PT (obtain before FFP transfusion if possible)
- aPTT
- Fibrinogen level (obtain before cryoprecipitate if possible)
- Platelet count
Step 4: Additional Considerations
- Platelet function testing may be considered if platelet dysfunction suspected (e.g., recent antiplatelet therapy) 1
- Activated clotting time (ACT) should be used routinely when heparin administered, particularly in cardiac/vascular surgery 2
Important Clinical Pitfalls
Don't Use These Tests for Routine Screening
Routine preoperative coagulation testing (PT/INR/aPTT) should NOT be used as general screening tools 4. A detailed bleeding history is more valuable than routine laboratory screening in predicting bleeding risk 5.
VHA Limitations to Recognize
- Requires trained operators for accurate interpretation 2
- Poor standardization across institutions (manufacturer reference ranges vary) 2
- Less sensitive for fibrinolytic activation in trauma—do not withhold tranexamic acid based solely on VHA results 2
- Age-dependent correlation issues: The correlation between functional fibrinogen (CFF-MA) and serum fibrinogen is notably weaker in infants 3
Timing Matters
Testing performed after protamine administration (in cardiac surgery) provides the best prediction of bleeding 6. Post-protamine MEA and TEM values inversely correlate with 24-hour chest tube output 6.
Point-of-Care Options
Newer systems expanding the armamentarium 2:
- Quantra™ (sonorrheometry-based)
- ClotPro™ (measures DOAC and antifibrinolytic effects)
- HemoCue™ or blood gas analysis for hemoglobin (correlates well with lab values) 2
These provide rapid results but share the standardization limitations of other VHAs.